10-K Filing

CELLDEX THERAPEUTICS, INC. CIK: 744218 FY 2011

Filing Information

Form Type	10-K
Accession Number	`0001047469-12-002276`
Period End Date	20111231
Filing Date	20120308
Fiscal Year	2011
Fiscal Period	FY
XBRL Instance	cldx-20111231.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 73 Income Statement 67 Cash Flow Statement 91 Stockholders Equity 30

Balance Sheet 73 line items

Line Item	Tag	Value	Unit	Period
Convertible Preferred Stock, Par Value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Convertible Preferred Stock, Par Value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Convertible Preferred Stock, Shares Authorized	`PreferredStockSharesAuthorized`	3.00M	shares	Point-in-time
Convertible Preferred Stock, Shares Authorized	`PreferredStockSharesAuthorized`	3.00M	shares	Point-in-time
Convertible Preferred Stock, Shares Issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Convertible Preferred Stock, Shares Issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Convertible Preferred Stock, Shares Outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Convertible Preferred Stock, Shares Outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Cash and Cash Equivalents	`CashAndCashEquivalentsAtCarryingValue`	$44.26M	USD	Point-in-time
Cash and Cash Equivalents	`CashAndCashEquivalentsAtCarryingValue`	$57.00M	USD	Point-in-time
Common Stock, Par Value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Cash and Cash Equivalents	`CashAndCashEquivalentsAtCarryingValue`	$21.29M	USD	Point-in-time
Cash and Cash Equivalents	`CashAndCashEquivalentsAtCarryingValue`	$11.90M	USD	Point-in-time
Common Stock, Par Value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Marketable Securities	`MarketableSecuritiesCurrent`	$41.41M	USD	Point-in-time
Common Stock, Shares Authorized	`CommonStockSharesAuthorized`	297.00M	shares	Point-in-time
Marketable Securities	`MarketableSecuritiesCurrent`	$39.81M	USD	Point-in-time
Common Stock, Shares Authorized	`CommonStockSharesAuthorized`	297.00M	shares	Point-in-time
Common Stock, Shares Issued	`CommonStockSharesIssued`	44.21M	shares	Point-in-time
Common Stock, Shares Issued	`CommonStockSharesIssued`	32.06M	shares	Point-in-time
Accounts and Other Receivables	`AccountsAndOtherReceivablesNetCurrent`	$170.00K	USD	Point-in-time
Accounts and Other Receivables	`AccountsAndOtherReceivablesNetCurrent`	$324.00K	USD	Point-in-time
Prepaid and Other Current Assets	`PrepaidExpenseAndOtherAssetsCurrent`	$1.52M	USD	Point-in-time
Prepaid and Other Current Assets	`PrepaidExpenseAndOtherAssetsCurrent`	$1.20M	USD	Point-in-time
Common Stock, Shares Outstanding	`CommonStockSharesOutstanding`	32.06M	shares	Point-in-time
Common Stock, Shares Outstanding	`CommonStockSharesOutstanding`	44.21M	shares	Point-in-time
Total Current Assets	`AssetsCurrent`	$54.68M	USD	Point-in-time
Total Current Assets	`AssetsCurrent`	$62.95M	USD	Point-in-time
Property and Equipment, Net	`PropertyPlantAndEquipmentNet`	$9.09M	USD	Point-in-time
Property and Equipment, Net	`PropertyPlantAndEquipmentNet`	$10.83M	USD	Point-in-time
Intangible Assets, Net	`IntangibleAssetsNetExcludingGoodwill`	$24.92M	USD	Point-in-time
Intangible Assets, Net	`IntangibleAssetsNetExcludingGoodwill`	$26.84M	USD	Point-in-time
Other Assets	`OtherAssetsNoncurrent`	$363.00K	USD	Point-in-time
Other Assets	`OtherAssetsNoncurrent`	$329.00K	USD	Point-in-time
Goodwill	`Goodwill`	$8.96M	USD	Point-in-time
Goodwill	`Goodwill`	$8.96M	USD	Point-in-time
Total Assets	`Assets`	$97.99M	USD	Point-in-time
Total Assets	`Assets`	$109.94M	USD	Point-in-time
Accounts Payable	`AccountsPayableCurrent`	$931.00K	USD	Point-in-time
Accounts Payable	`AccountsPayableCurrent`	$935.00K	USD	Point-in-time
Accrued Expenses	`AccruedLiabilitiesCurrent`	$4.94M	USD	Point-in-time
Accrued Expenses	`AccruedLiabilitiesCurrent`	$7.01M	USD	Point-in-time
Current Portion of Long-Term Liabilities	`OtherLiabilitiesCurrent`	$818.00K	USD	Point-in-time
Current Portion of Long-Term Liabilities	`OtherLiabilitiesCurrent`	$219.00K	USD	Point-in-time
Current Portion of Term Loan	`SecuredDebtCurrent`	$6.14M	USD	Point-in-time
Current Portion of Term Loan	`SecuredDebtCurrent`	$1.11M	USD	Point-in-time
Convertible Subordinated Debt	`ConvertibleSubordinatedDebtCurrent`	$12.41M	USD	Point-in-time
Total Current Liabilities	`LiabilitiesCurrent`	$20.21M	USD	Point-in-time
Total Current Liabilities	`LiabilitiesCurrent`	$14.30M	USD	Point-in-time
Term Loan, less Current Portion	`SecuredLongTermDebt`	$8.89M	USD	Point-in-time
Term Loan, less Current Portion	`SecuredLongTermDebt`	$9.01M	USD	Point-in-time
Other Long-Term Liabilities	`OtherLiabilitiesNoncurrent`	$5.97M	USD	Point-in-time
Other Long-Term Liabilities	`OtherLiabilitiesNoncurrent`	$5.59M	USD	Point-in-time
Total Liabilities	`Liabilities`	$29.27M	USD	Point-in-time
Total Liabilities	`Liabilities`	$34.69M	USD	Point-in-time
Commitments and Contingent Liabilities (Notes 14 and 16)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and Contingent Liabilities (Notes 14 and 16)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Convertible Preferred Stock, $.01 Par Value; 3,000,000 Shares Authorized; No Shares Issued and Outstanding at December 31, 2011 and 2010	`PreferredStockValue`	-	USD	Point-in-time
Convertible Preferred Stock, $.01 Par Value; 3,000,000 Shares Authorized; No Shares Issued and Outstanding at December 31, 2011 and 2010	`PreferredStockValue`	-	USD	Point-in-time
Common Stock, $.001 Par Value; 297,000,000 Shares Authorized; 44,210,636 and 32,055,382 Shares Issued and Outstanding at December 31, 2011 and 2010, respectively	`CommonStockValue`	$32.00K	USD	Point-in-time
Common Stock, $.001 Par Value; 297,000,000 Shares Authorized; 44,210,636 and 32,055,382 Shares Issued and Outstanding at December 31, 2011 and 2010, respectively	`CommonStockValue`	$44.00K	USD	Point-in-time
Additional Paid-In Capital	`AdditionalPaidInCapitalCommonStock`	$271.03M	USD	Point-in-time
Additional Paid-In Capital	`AdditionalPaidInCapitalCommonStock`	$232.68M	USD	Point-in-time
Accumulated Other Comprehensive Income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$2.75M	USD	Point-in-time
Accumulated Other Comprehensive Income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$2.65M	USD	Point-in-time
Accumulated Deficit	`RetainedEarningsAccumulatedDeficit`	$-160.21M	USD	Point-in-time
Accumulated Deficit	`RetainedEarningsAccumulatedDeficit`	$-205.01M	USD	Point-in-time
Total Stockholders' Equity	`StockholdersEquity`	$73.77M	USD	Point-in-time
Total Stockholders' Equity	`StockholdersEquity`	$68.72M	USD	Point-in-time
Total Stockholders' Equity	`StockholdersEquity`	$18.13M	USD	Point-in-time
Total Stockholders' Equity	`StockholdersEquity`	$75.25M	USD	Point-in-time
Total Liabilities and Stockholders' Equity	`LiabilitiesAndStockholdersEquity`	$97.99M	USD	Point-in-time
Total Liabilities and Stockholders' Equity	`LiabilitiesAndStockholdersEquity`	$109.94M	USD	Point-in-time

Income Statement 67 line items

Line Item	Tag	Value	Unit	Period
Product Development and Licensing Agreements	`RevenueFromProductDevelopmentAndLicensingAgreements`	$5.66M	USD	Annual
Product Development and Licensing Agreements	`RevenueFromProductDevelopmentAndLicensingAgreements`	$40.19M	USD	Annual
Product Development and Licensing Agreements	`RevenueFromProductDevelopmentAndLicensingAgreements`	$110.00K	USD	Annual
Contracts and Grants	`RevenueFromContractsAndGrants`	$1.80M	USD	Annual
Contracts and Grants	`RevenueFromContractsAndGrants`	$36.00K	USD	Annual
Contracts and Grants	`RevenueFromContractsAndGrants`	$220.00K	USD	Annual
Product Royalties	`RoyaltyRevenue`	$9.12M	USD	Annual
Product Royalties	`RoyaltyRevenue`	$7.72M	USD	Annual
Product Royalties	`RoyaltyRevenue`	$6.39M	USD	Annual
Total Revenue	`Revenues`	$15.18M	USD	Annual
Total Revenue	`Revenues`	$9.27M	USD	Annual
Total Revenue	`Revenues`	$46.79M	USD	Annual
Research and Development	`ResearchAndDevelopmentExpense`	$26.17M	USD	Annual
Research and Development	`ResearchAndDevelopmentExpense`	$32.44M	USD	Annual
Research and Development	`ResearchAndDevelopmentExpense`	$27.65M	USD	Annual
Royalty	`RoyaltyExpense`	$9.12M	USD	Annual
Royalty	`RoyaltyExpense`	$12.08M	USD	Annual
Royalty	`RoyaltyExpense`	$8.40M	USD	Annual
Gain on Sale of Assets	`GainLossOnDispositionOfAssets`	$50.00K	USD	Annual
Gain on Sale of Assets	`GainLossOnDispositionOfAssets`	$50.00K	USD	Annual
Gain on Sale of Assets	`GainLossOnDispositionOfAssets`	$604.00K	USD	Annual
General and Administrative	`GeneralAndAdministrativeExpense`	$17.12M	USD	Annual
General and Administrative	`GeneralAndAdministrativeExpense`	$10.43M	USD	Annual
General and Administrative	`GeneralAndAdministrativeExpense`	$9.24M	USD	Annual
Amortization of Acquired Intangible Assets	`AmortizationOfIntangibleAssets`	$3.14M	USD	Annual
Amortization of Acquired Intangible Assets	`AmortizationOfIntangibleAssets`	$1.91M	USD	Annual
Amortization of Acquired Intangible Assets	`AmortizationOfIntangibleAssets`	$949.00K	USD	Annual
Total Operating Expense	`CostsAndExpenses`	$53.25M	USD	Annual
Total Operating Expense	`CostsAndExpenses`	$52.66M	USD	Annual
Total Operating Expense	`CostsAndExpenses`	$52.03M	USD	Annual
Operating Loss	`OperatingIncomeLoss`	$-6.46M	USD	Annual
Operating Loss	`OperatingIncomeLoss`	$-43.40M	USD	Annual
Operating Loss	`OperatingIncomeLoss`	$-36.85M	USD	Annual
Investment and Other Income, Net	`NonoperatingIncomeExpense`	$5.26M	USD	Annual
Investment and Other Income, Net	`NonoperatingIncomeExpense`	$248.00K	USD	Annual
Investment and Other Income, Net	`NonoperatingIncomeExpense`	$396.00K	USD	Annual
Interest Expense	`InterestExpense`	$1.80M	USD	Annual
Interest Expense	`InterestExpense`	$1.34M	USD	Annual
Interest Expense	`InterestExpense`	$452.00K	USD	Annual
Net Loss Before Income Taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-37.05M	USD	Annual
Net Loss Before Income Taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-44.80M	USD	Annual
Net Loss Before Income Taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-2.53M	USD	Annual
Income Tax Benefit	`IncomeTaxExpenseBenefit`	$-529.00K	USD	Annual
Net Loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-2.53M	USD	Annual
Net Loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-44.80M	USD	Annual
Net Loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-36.52M	USD	Annual
Basic and Diluted Net Loss Per Common Share (See Note 2) (in dollars per share)	`EarningsPerShareBasicAndDiluted`	$-1.13	USD	Annual
Basic and Diluted Net Loss Per Common Share (See Note 2) (in dollars per share)	`EarningsPerShareBasicAndDiluted`	$-0.08	USD	Annual
Basic and Diluted Net Loss Per Common Share (See Note 2) (in dollars per share)	`EarningsPerShareBasicAndDiluted`	$-1.84	USD	Annual
Shares Used in Calculating Basic Net Loss per Share (See Note 2) (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	39.50M	shares	Annual
Shares Used in Calculating Basic Net Loss per Share (See Note 2) (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	19.82M	shares	Annual
Shares Used in Calculating Basic Net Loss per Share (See Note 2) (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	31.87M	shares	Annual
Shares Used in Calculating Diluted Net Loss per Share (See Note 2) (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	31.87M	shares	Annual
Shares Used in Calculating Diluted Net Loss per Share (See Note 2) (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	39.50M	shares	Annual
Shares Used in Calculating Diluted Net Loss per Share (See Note 2) (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	19.82M	shares	Annual
Net Loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-2.53M	USD	Annual
Net Loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-44.80M	USD	Annual
Net Loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-36.52M	USD	Annual
Foreign Currency Translation Adjustments	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent`	$-9.00K	USD	Annual
Foreign Currency Translation Adjustments	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent`	$-12.00K	USD	Annual
Foreign Currency Translation Adjustments	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent`	$2.00K	USD	Annual
Unrealized (Loss) Gain on Marketable Securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-90.00K	USD	Annual
Unrealized (Loss) Gain on Marketable Securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-48.00K	USD	Annual
Unrealized (Loss) Gain on Marketable Securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$203.00K	USD	Annual
Comprehensive Loss	`ComprehensiveIncomeNetOfTax`	$-44.90M	USD	Annual
Comprehensive Loss	`ComprehensiveIncomeNetOfTax`	$-2.33M	USD	Annual
Comprehensive Loss	`ComprehensiveIncomeNetOfTax`	$-36.59M	USD	Annual

Cash Flow Statement 91 line items

Line Item	Tag	Value	Unit	Period
Net Loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-2.53M	USD	Annual
Net Loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-44.80M	USD	Annual
Net Loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-36.52M	USD	Annual
Depreciation and Amortization	`DepreciationDepletionAndAmortization`	$2.58M	USD	Annual
Depreciation and Amortization	`DepreciationDepletionAndAmortization`	$2.72M	USD	Annual
Depreciation and Amortization	`DepreciationDepletionAndAmortization`	$2.25M	USD	Annual
Amortization of Intangible Assets	`AmortizationOfIntangibleAssets`	$3.14M	USD	Annual
Amortization of Intangible Assets	`AmortizationOfIntangibleAssets`	$1.91M	USD	Annual
Amortization of Intangible Assets	`AmortizationOfIntangibleAssets`	$949.00K	USD	Annual
Amortization and Premium of Marketable Securities	`AccretionAmortizationOfDiscountsAndPremiumsInvestments`	$14.00K	USD	Annual
Amortization and Premium of Marketable Securities	`AccretionAmortizationOfDiscountsAndPremiumsInvestments`	$-17.00K	USD	Annual
Realized Loss (Gain) on Sales and Maturities of Marketable Securities	`MarketableSecuritiesGainLoss`	$4.00K	USD	Annual
Realized Loss (Gain) on Sales and Maturities of Marketable Securities	`MarketableSecuritiesGainLoss`	$-24.00K	USD	Annual
Realized Loss (Gain) on Sales and Maturities of Marketable Securities	`MarketableSecuritiesGainLoss`	$-5.00K	USD	Annual
(Gain) Loss on Sale or Disposal of Assets	`GainLossOnSaleOfPropertyPlantEquipment`	$38.00K	USD	Annual
(Gain) Loss on Sale or Disposal of Assets	`GainLossOnSaleOfPropertyPlantEquipment`	$58.00K	USD	Annual
(Gain) Loss on Sale or Disposal of Assets	`GainLossOnSaleOfPropertyPlantEquipment`	$556.00K	USD	Annual
Stock-Based Compensation Expense	`ShareBasedCompensation`	$2.80M	USD	Annual
Stock-Based Compensation Expense	`ShareBasedCompensation`	$2.34M	USD	Annual
Stock-Based Compensation Expense	`ShareBasedCompensation`	$3.06M	USD	Annual
Non-Cash Interest Expense	`AmortizationOfDebtDiscountPremium`	$181.00K	USD	Annual
Non-Cash Interest Expense	`AmortizationOfDebtDiscountPremium`	$728.00K	USD	Annual
Non-Cash Interest Expense	`AmortizationOfDebtDiscountPremium`	$307.00K	USD	Annual
Non-Cash Tax Benefit	`OtherNoncashIncomeTaxExpense`	$-529.00K	USD	Annual
Accounts and Other Receivables	`IncreaseDecreaseInAccountsAndOtherReceivables`	$-1.28M	USD	Annual
Accounts and Other Receivables	`IncreaseDecreaseInAccountsAndOtherReceivables`	$-154.00K	USD	Annual
Accounts and Other Receivables	`IncreaseDecreaseInAccountsAndOtherReceivables`	$-220.00K	USD	Annual
Prepaid and Other Current Assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$546.00K	USD	Annual
Prepaid and Other Current Assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-743.00K	USD	Annual
Prepaid and Other Current Assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-241.00K	USD	Annual
Other Assets	`IncreaseDecreaseInOtherOperatingAssets`	$-34.00K	USD	Annual
Other Assets	`IncreaseDecreaseInOtherOperatingAssets`	$-5.59M	USD	Annual
Other Assets	`IncreaseDecreaseInOtherOperatingAssets`	$-722.00K	USD	Annual
Accounts Payable and Accrued Expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-2.46M	USD	Annual
Accounts Payable and Accrued Expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$2.08M	USD	Annual
Accounts Payable and Accrued Expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-1.19M	USD	Annual
Deferred Revenue	`IncreaseDecreaseInDeferredRevenue`	$-2.04M	USD	Annual
Deferred Revenue	`IncreaseDecreaseInDeferredRevenue`	$-39.38M	USD	Annual
Other Liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$-138.00K	USD	Annual
Other Liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$-1.86M	USD	Annual
Other Liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$2.70M	USD	Annual
Net Cash Used in Operating Activities	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$-29.87M	USD	Annual
Net Cash Used in Operating Activities	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$-30.37M	USD	Annual
Net Cash Used in Operating Activities	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$-35.66M	USD	Annual
Cash Acquired in the CuraGen acquisition	`CashAcquiredFromAcquisition`	$51.65M	USD	Annual
Sales and Maturities of Marketable Securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$51.00M	USD	Annual
Sales and Maturities of Marketable Securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$2.67M	USD	Annual
Sales and Maturities of Marketable Securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$42.38M	USD	Annual
Purchases of Marketable Securities	`PaymentsToAcquireMarketableSecurities`	$52.72M	USD	Annual
Purchases of Marketable Securities	`PaymentsToAcquireMarketableSecurities`	$56.52M	USD	Annual
Purchases of Marketable Securities	`PaymentsToAcquireMarketableSecurities`	$9.56M	USD	Annual
Acquisition of Property and Equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$509.00K	USD	Annual
Acquisition of Property and Equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$528.00K	USD	Annual
Acquisition of Property and Equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$2.10M	USD	Annual
Proceeds from Sale or Disposal of Assets	`ProceedsFromSaleOfProductiveAssets`	$68.00K	USD	Annual
Proceeds from Sale or Disposal of Assets	`ProceedsFromSaleOfProductiveAssets`	$77.00K	USD	Annual
Proceeds from Sale or Disposal of Assets	`ProceedsFromSaleOfProductiveAssets`	$850.00K	USD	Annual
Net Cash (Used in) Provided by Investing Activities	`NetCashProvidedByUsedInInvestingActivitiesContinuingOperations`	$-2.15M	USD	Annual
Net Cash (Used in) Provided by Investing Activities	`NetCashProvidedByUsedInInvestingActivitiesContinuingOperations`	$45.09M	USD	Annual
Net Cash (Used in) Provided by Investing Activities	`NetCashProvidedByUsedInInvestingActivitiesContinuingOperations`	$-16.16M	USD	Annual
Net Proceeds from Stock Issuances	`ProceedsFromIssuanceOfCommonStock`	$1.01M	USD	Annual
Net Proceeds from Stock Issuances	`ProceedsFromIssuanceOfCommonStock`	$668.00K	USD	Annual
Net Proceeds from Stock Issuances	`ProceedsFromIssuanceOfCommonStock`	$36.02M	USD	Annual
Related Party Loan Due to Medarex	`RepaymentsOfSubordinatedDebt`	$2.96M	USD	Annual
Issuance of Term Loan	`ProceedsFromIssuanceOfLongTermDebt`	$5.00M	USD	Annual
Issuance of Term Loan	`ProceedsFromIssuanceOfLongTermDebt`	$10.00M	USD	Annual
Payment of Convertible Subordinated Debt	`RepaymentsOfConvertibleDebt`	$12.50M	USD	Annual
Payment of Other Liabilities	`RepaymentsOfOtherLongTermDebt`	$176.00K	USD	Annual
Payment of Other Liabilities	`RepaymentsOfOtherLongTermDebt`	$197.00K	USD	Annual
Payment of Other Liabilities	`RepaymentsOfOtherLongTermDebt`	$86.00K	USD	Annual
Net Cash Provided by (Used in) Financing Activities	`NetCashProvidedByUsedInFinancingActivitiesContinuingOperations`	$28.43M	USD	Annual
Net Cash Provided by (Used in) Financing Activities	`NetCashProvidedByUsedInFinancingActivitiesContinuingOperations`	$10.82M	USD	Annual
Net Cash Provided by (Used in) Financing Activities	`NetCashProvidedByUsedInFinancingActivitiesContinuingOperations`	$-2.46M	USD	Annual
Effect of Exchange Rate Changes on Cash and Cash Equivalents	`EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations`	$2.00K	USD	Annual
Effect of Exchange Rate Changes on Cash and Cash Equivalents	`EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations`	$-12.00K	USD	Annual
Effect of Exchange Rate Changes on Cash and Cash Equivalents	`EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations`	$-9.00K	USD	Annual
Net (Decrease) Increase in Cash and Cash Equivalents	`NetCashProvidedByUsedInContinuingOperations`	$-35.72M	USD	Annual
Net (Decrease) Increase in Cash and Cash Equivalents	`NetCashProvidedByUsedInContinuingOperations`	$-9.39M	USD	Annual
Net (Decrease) Increase in Cash and Cash Equivalents	`NetCashProvidedByUsedInContinuingOperations`	$12.74M	USD	Annual
Cash and Cash Equivalents at Beginning of Period	`CashAndCashEquivalentsAtCarryingValue`	$44.26M	USD	Point-in-time
Cash and Cash Equivalents at Beginning of Period	`CashAndCashEquivalentsAtCarryingValue`	$57.00M	USD	Point-in-time
Cash and Cash Equivalents at Beginning of Period	`CashAndCashEquivalentsAtCarryingValue`	$21.29M	USD	Point-in-time
Cash and Cash Equivalents at Beginning of Period	`CashAndCashEquivalentsAtCarryingValue`	$11.90M	USD	Point-in-time
Cash and Cash Equivalents at End of Period	`CashAndCashEquivalentsAtCarryingValue`	$44.26M	USD	Point-in-time
Cash and Cash Equivalents at End of Period	`CashAndCashEquivalentsAtCarryingValue`	$57.00M	USD	Point-in-time
Cash and Cash Equivalents at End of Period	`CashAndCashEquivalentsAtCarryingValue`	$21.29M	USD	Point-in-time
Cash and Cash Equivalents at End of Period	`CashAndCashEquivalentsAtCarryingValue`	$11.90M	USD	Point-in-time
Shares Issued to Executive Officers	`StockGrantedDuringPeriodValueSharebasedCompensation`	$250.00K	USD	Annual
Cash Paid for Interest	`InterestPaid`	$604.00K	USD	Annual
Cash Paid for Interest	`InterestPaid`	$1.56M	USD	Annual
Cash Paid for Interest	`InterestPaid`	$157.00K	USD	Annual

Stockholders Equity 30 line items

Line Item	Tag	Value	Unit	Period
Balance	`StockholdersEquity`	$73.77M	USD	Point-in-time
Balance	`StockholdersEquity`	$68.72M	USD	Point-in-time
Balance	`StockholdersEquity`	$18.13M	USD	Point-in-time
Balance	`StockholdersEquity`	$75.25M	USD	Point-in-time
Balance (in shares)	`CommonStockSharesIssued`	44.21M	shares	Point-in-time
Balance (in shares)	`CommonStockSharesIssued`	32.06M	shares	Point-in-time
Shares Issued under Stock Option and Employee Stock Purchase Plans	`StockIssuedDuringPeriodValueEmployeeStockPurchasePlan`	$917.00K	USD	Annual
Shares Issued under Stock Option and Employee Stock Purchase Plans	`StockIssuedDuringPeriodValueEmployeeStockPurchasePlan`	$1.01M	USD	Annual
Shares Issued under Stock Option and Employee Stock Purchase Plans	`StockIssuedDuringPeriodValueEmployeeStockPurchasePlan`	$173.00K	USD	Annual
Shares Issued in Connection with Cantor Agreement	`StockIssuedDuringPeriodValueOther`	$2.15M	USD	Annual
Shares Issued in Connection with the CuraGen acquisition	`StockIssuedDuringPeriodValueAcquisitions`	$88.24M	USD	Annual
Shares Issued in Underwritten Offering	`StockIssuedDuringPeriodValueNewIssues`	$33.70M	USD	Annual
Share-Based Compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$3.06M	USD	Annual
Share-Based Compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$2.80M	USD	Annual
Share-Based Compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$2.34M	USD	Annual
Foreign Currency Translation Adjustments	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent`	$-9.00K	USD	Annual
Foreign Currency Translation Adjustments	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent`	$-12.00K	USD	Annual
Foreign Currency Translation Adjustments	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent`	$2.00K	USD	Annual
Unrealized (Loss) Gain on Marketable Securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-90.00K	USD	Annual
Unrealized (Loss) Gain on Marketable Securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-48.00K	USD	Annual
Unrealized (Loss) Gain on Marketable Securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$203.00K	USD	Annual
Net Loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-2.53M	USD	Annual
Net Loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-44.80M	USD	Annual
Net Loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-36.52M	USD	Annual
Balance	`StockholdersEquity`	$73.77M	USD	Point-in-time
Balance	`StockholdersEquity`	$68.72M	USD	Point-in-time
Balance	`StockholdersEquity`	$18.13M	USD	Point-in-time
Balance	`StockholdersEquity`	$75.25M	USD	Point-in-time
Balance (in shares)	`CommonStockSharesIssued`	44.21M	shares	Point-in-time
Balance (in shares)	`CommonStockSharesIssued`	32.06M	shares	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.